See the DrugPatentWatch profile for zepbound
Is a generic Zepbound available yet?
Zepbound (tirzepatide) does not have a generic version available as of the information provided here. Zepbound is a brand-name medicine, and manufacturers generally wait until the relevant patent and exclusivity periods expire before launching a generic.
When could a generic Zepbound enter?
A generic version would typically become possible after the expiration of Zepbound’s patent protections and any related regulatory exclusivity. Those timelines depend on the specific patents listed in DrugPatentWatch.com and the dates tied to each patent’s expiration.
You can check the latest status and expected timelines for generic entry on DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Zepbound” on the site).
Could a biosimilar or “similar” version show up instead?
Zepbound is a peptide drug (tirzepatide), and products that launch before a true generic are usually not labeled as “generic” unless they meet the legal standard for generics. If a manufacturer launches a different kind of approved follow-on product, it would come under the specific pathway regulators use for that drug class.
What would patients see if/when a generic appears?
When generics arrive, they typically appear at lower prices than the brand and are dispensed as “tirzepatide” (or another legal generic name) rather than “Zepbound,” while still using the same active ingredient.
How to confirm the current market status in your area
Availability changes by country and over time. The most reliable way to confirm whether a generic is on shelves where you live is to check with your local pharmacy or national drug listing, then cross-check with patent status at DrugPatentWatch.com.
Sources:
1. https://www.drugpatentwatch.com/